What is your plan to change the world?
Learn about the remarkable personal and professional achievements of Dr. Greg Bailey, a leading figure in health and longevity.
- Dr. Greg Bailey
My Why
Prioritizing Prevention
Health Care Trajectory
Health Economics
Biotech Investment
A Path to Vitality
Prioritizing health and longevity isn't just about living longer; it's about living better. Dr. Bailey's insights pave the way to a life filled with energy, vigor, and vitality.
Empowering Wellness
Dr. Bailey's visionary approach empowers individuals to take control of their well-being. Gain the knowledge and tools to make informed decisions about your health.
Inspiring Innovation
Dr. Bailey's journey exemplifies the power of innovation. Learn how forward-thinking strategies can reshape industries and create lasting impact.
Masterful Communication
Dr. Bailey possesses a unique talent for simplifying complex scientific and medical concepts, making them accessible to all.
Leading with Science
In an ever-evolving field, Dr. Bailey stands at the forefront of scientific breakthroughs. Trust in evidence-based strategies that have the potential to transform lives.
Elevating Humanity
Beyond personal benefits, embracing health and longevity contributes to a healthier, more resilient society. Join the movement towards a brighter future for all.
Dr. Greg Bailey's Mission
Prevention
Investment
Healthcare
Trajectory
Benefits of
Prevention
Dr. Greg Bailey Career Highlights
Dr Bailey, along with his partners, have built numerous multibillion dollar companies and developed lifesaving drugs. This has positioned him as a leading voice discussing longevity, biotech investing and well being.
Explore the key milestones and accomplishments in Dr. Bailey's life and career, from today to his early years.
Present
Co-Founder, Former CEO
Dr. Bailey is leveraging his extensive drug and corporate development expertise to bring transformative products to the market. Juvenescence currently has 11 products in development five of which are set to undergo clinical trials aimed at slowing down, altering or reversing the aging process these could have enormous ramifications for humanity.
To date Juvenescence has successfully raised $294 million.
2018
Co-Founder, Non-executive Director
(LSE:MFX) Financial services group that owns a tier 1 bank, amongst other financial assets.
2016
Co-Founder & Financier
Dr. Bailey's foray into the insurance industry began when he partnered with Nilesh Vasani, founder of Chelsea Avondale Insurance, by investing $25 million to build a successful insurance company. Through innovation and strategic financing, they have outperformed industry norms, securing an additional $70 million in funding.
2014
Original Financier & Board Member
(BHVN:NYSE) Biohaven pharmaceutical company focused on psychiatric and neurological diseases. Sold one of the drugs in its portfolio to Pfizer for $11.6 billion. Dr Bailey played a pivotal role in the structure of the company and leading the seed financing.
2013
Co-Founder & Former Chairman
(PRTG:NASDAQ) Following his usual model of investing in multiple products Portage ended up investing $7 million into Biohaven which at the time of the Pfizer acquisition was worth $900 million. The company is now looking for multiple opportunities in immuno-oncology.
2006
Co-Founder
(VHC: AMEX) The company was an unusual opportunity where Dr. Bailey licensed technology from SAIC to create a product for secure communication. To commercialize its opportunity it unfortunately ended a legal case which resulted in Microsoft paying $200 million and the company's market cap going to $2 billion.
2005
Founder, Director
Dr Bailey was an initial financier and an independent director of Medivation. The company following a portfolio model went on to develop one of the leading drugs in the world for prostate cancer. In 2016 the company would be acquired by Pfizer for $14.3 billion.
1995
Founder
As a founding member of Ascent Healthcare, Dr. Bailey pursued a gap in the market, successfully turning around under-utilized hospital equipment into a thriving business. The venture was eventually sold for $521 million to Stryker.
1985
Investor
Capitalizing on the real estate boom of the 80s, Dr. Bailey, along with partners, found success in transforming under-utilized commercial properties into medical facilities.
1982
ER Doctor
Practiced emergency medicine for a decade.
1981
Graduate
Dr. Greg Bailey receives his MD from Western University in Ontario, Canada.
See Dr. Bailey's Daily Dose
Get a comprehensive look at the vitamins, supplements, and daily routine that Dr. Bailey has used to rewind time.